News About: Pharm. Industry
KHIPA to hold explanatory meeting for IT-BT fusion technology projects.
The Korea Health Industry Promotion Agency (KHIPA) will have an explanatory meeting for an outstanding IT-BT fusion technology at Coex Atlanatic hall from June 18 to 21 as an event of "IT Technomart 2003" sponsored by...
Product line diversification, a success key for long-term profitability.
McKinsy Korea research team comprising of Mr. Huh Ho-young, Mr. Chung Wook-jin and Ms. Song In-sook, a Korea branch of a world renowned consulting company, indicated through their article contributed to Yakup press th...
KFDA to withhold Iressa registration.
The KFDA withheld the health registration of Iressa, an anti-cancer drug for a non-small cell lung cancer, filed by AstraZeneca Korea, claiming that the required dissolution test data and its related results were not ...
MSD to launch anti-fungal drug, Cancidas in June.MSD Korea will launch Cancidas 70mg and 50mg strength (IV injection) for the treatment of fungal infections probably during June.
Mode of Cancidas (caspofungin acetate) actio...
|
AstraZenca's new drug for stroke conducting phase IIB study in Korea
AstraZeneca announced that the phase IIB study on the new drug for stroke (Stroke Acute Ischemic NXY-059 Treatment: SAINT) seems to be conducted for the first time in Korea.
The clinical study for NXY-059 (brand na...
Smaller package sizes favored by some drug makers
Some pharmaceutical firms are opting for release of smaller package units of OTCs (e.g., one, six or 12 tablets/capsules) in a bid to boost their sales at the domestic pharmacy market without price hikes.
Choong-wa...
Finished drug exports remarkably grew up in lst quarter.
The total pharmaceutical export for the lst quarter of this year showed a comparable level with the same period last year but the export value of finished drugs substantially jumped up.
According to the...
OTC-oriented pharmaceutical firms struggling to boost sales
OTC pharmaceutical firms are moving to increase the sales of summer-season drugs towards the domestic pharmacy market as part of their efforts to boost their bottom lines.
These firms are offering lots of premiums...
Chinese pharmaceutical machinery business expands rapidly
KOTRA-China said in a recent report citing a Chinese business source that a large pharmaceutical machinery maker in China has been making a 24-hour operation to meet the explosive demand with a plan to expand the prod...
Domestic pharmaceutical firms urged to introduce special team system for specific therapeutic groups
Pharmaceutical business say that for their better competitiveness local pharmaceutical makers should positively brace for introducing a special team to promote a certain therapeutic category, as the majority of foreig...
